Clinical Trial Detail

NCT ID NCT02319837
Title Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
Recruitment Active, not recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Medivation, Inc.
Indications

prostate adenocarcinoma

Therapies

Leuprolide

Enzalutamide

Age Groups: adult

No variant requirements are available.